Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) FCF Margin (2020 - 2025)

Historic FCF Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 12.46%.

  • Burning Rock Biotech's FCF Margin rose 989900.0% to 12.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.43%, marking a year-over-year increase of 306000.0%. This contributed to the annual value of 18.94% for FY2024, which is 301600.0% up from last year.
  • As of Q3 2025, Burning Rock Biotech's FCF Margin stood at 12.46%, which was up 989900.0% from 45.69% recorded in Q2 2025.
  • Burning Rock Biotech's FCF Margin's 5-year high stood at 15.12% during Q4 2024, with a 5-year trough of 321.17% in Q4 2022.
  • In the last 5 years, Burning Rock Biotech's FCF Margin had a median value of 76.24% in 2021 and averaged 70.97%.
  • Per our database at Business Quant, Burning Rock Biotech's FCF Margin crashed by -2449300bps in 2022 and then skyrocketed by 3079400bps in 2023.
  • Burning Rock Biotech's FCF Margin (Quarter) stood at 76.24% in 2021, then plummeted by -321bps to 321.17% in 2022, then skyrocketed by 96bps to 13.23% in 2023, then skyrocketed by 214bps to 15.12% in 2024, then decreased by -18bps to 12.46% in 2025.
  • Its FCF Margin stands at 12.46% for Q3 2025, versus 45.69% for Q2 2025 and 17.68% for Q1 2025.